Family business successions are often a disaster. At ResMed, the global sleep device manufacturer, it has proven to be a ...

The outcome of this study could significantly impact Sanofi’s stock performance and investor sentiment, especially if Lunsekimig proves to be effective. This development could position Sanofi ...

This update could positively impact Sanofi’s stock performance by showcasing their commitment to advancing asthma treatments. Investor sentiment may be bolstered by the potential of Lunsekimig to ...

Sanofi’s shift to immunology, AI-driven R&D, and strong pipeline offset risks from patent cliffs and legal issues. See why ...

For over a decade, Europe has used joint procurement to access medical supplies. Before the pandemic, that included hospital supplies, pandemic flu shots and antivirals. It expanded to the ...

O'Reilly Automotive Inc. is suing the three major pharmacy benefit managers in the U.S., as well as the three major insulin manufacturers.

Paris Thursday, August 7, 2025, 10:00 Hrs [IST] Sanofi announces the completion of its acquisition of Vigil Neuroscience, I ...

Novavax posted a surprise profit in Q2 2025, reporting GAAP EPS of $0.62 compared to an expected loss of $0.04 per share. Revenue (GAAP) was $239 million, well above the analyst estimate of $152.61 ...